DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

Geron Corp (NASDAQ: GERN)

3.01 0.32 (11.90%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $3.01 11.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.67
Previous Close $2.69
Daily Range $2.65 - $3.02
52-Week Range $1.76 - $4.67
Market Cap $476.0M
P/E Ratio -11.21
Dividend (Yield) $0.00 (0.0%)
Volume 2,856,257
Average Daily Volume 3,506,678
Current FY EPS -$0.05




Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary

This Small-Cap Biotech Could Wind Up Devouring a Much Larger Foe's Revenue Stream

Representing a true David versus Goliath battle in the biotech space, this $500 million cancer drug developer could soon dethrone a $21 billion giant.

Can Geron (GERN) Run Higher on Strong Earnings Estimate Revisions?

One Way To Bet On The American Society Of Hematology's Meeting Next Month

Today's Perilous Reversal Stock: Geron (GERN)

'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy

Strong On High Relative Volume: Geron (GERN)

Geron: Calculating The Potential Value Gap

Morning Market Gainers

Health Care Sector Update for 09/16/2015: BMY, AGN, GERN

Benzinga's Top #PreMarket Gainers

Benzinga's Top #PreMarket Gainers

See More GERN News...

GERN's Top Competitors

GERN $3.01 (11.90%)
Current stock: GERN
AMGN $142.47 (1.60%)
Current stock: AMGN
BIIB $290.35 (1.06%)
Current stock: BIIB
CELG $116.39 (3.13%)
Current stock: CELG